APA (7th ed.) Citation

Lorusso, D., Gladieff, L., O'Malley, D. M., Kim, J., Garbaos, G., Fagotti, A., . . . Salutari, V. (2026). Overall survival with relacorilant and nab-paclitaxel in patients with platinum-resistant ovarian cancer (ROSELLA): A phase 3 randomised controlled trial. Lancet, 407(10538), 1513. https://doi.org/10.1016/S0140-6736(26)00462-9

Chicago Style (17th ed.) Citation

Lorusso, Domenica, et al. "Overall Survival with Relacorilant and Nab-paclitaxel in Patients with Platinum-resistant Ovarian Cancer (ROSELLA): A Phase 3 Randomised Controlled Trial." Lancet 407, no. 10538 (2026): 1513. https://doi.org/10.1016/S0140-6736(26)00462-9.

MLA (9th ed.) Citation

Lorusso, Domenica, et al. "Overall Survival with Relacorilant and Nab-paclitaxel in Patients with Platinum-resistant Ovarian Cancer (ROSELLA): A Phase 3 Randomised Controlled Trial." Lancet, vol. 407, no. 10538, 2026, p. 1513, https://doi.org/10.1016/S0140-6736(26)00462-9.